Cargando…
Treating insomnia symptoms with medicinal cannabis: a randomized, crossover trial of the efficacy of a cannabinoid medicine compared with placebo
STUDY OBJECTIVES: This randomized, double-blind, placebo-controlled, crossover study was conducted to evaluate the safety and efficacy of 2 weeks of nightly sublingual cannabinoid extract (ZTL-101) in treating chronic insomnia (symptoms ≥3 months). METHODS: Co-primary study endpoints were safety of...
Autores principales: | Walsh, Jennifer H, Maddison, Kathleen J, Rankin, Tim, Murray, Kevin, McArdle, Nigel, Ree, Melissa J, Hillman, David R, Eastwood, Peter R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598183/ https://www.ncbi.nlm.nih.gov/pubmed/34115851 http://dx.doi.org/10.1093/sleep/zsab149 |
Ejemplares similares
-
Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2
por: Kärppä, Mikko, et al.
Publicado: (2020) -
The natural history of insomnia: predisposing, precipitating, coping, and perpetuating factors over the early developmental course of insomnia
por: Ellis, Jason G, et al.
Publicado: (2021) -
Consistent altered internal capsule white matter microstructure in insomnia disorder
por: Bresser, Tom, et al.
Publicado: (2020) -
Insomnia in the context of short sleep increases suicide risk
por: Anna Karin, Hedström, et al.
Publicado: (2020) -
Does providing feedback and guidance on sleep perceptions using sleep wearables improve insomnia? Findings from “Novel Insomnia Treatment Experiment”: a randomized controlled trial
por: Spina, Marie-Antoinette, et al.
Publicado: (2023)